These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3064254)

  • 21. [The role of Agreal in the treatment of the menopause].
    Marais C
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):156-62. PubMed ID: 3992113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tolerance to veralipride administered for an extended time].
    Milliez J
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):27-8, 31. PubMed ID: 6531585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of early menopause. A report of 2 cases].
    Gicquel A
    Sem Hop; 1983 Jan; 59(1):47-8. PubMed ID: 6297087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and clinical and biological tolerability of the long-term administration of veralipride. Apropos of 74 cases].
    Dargent D; Dumont M; Malinas Y
    Sem Hop; 1983 Nov; 59(40):2778-80. PubMed ID: 6316535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety of veralipride.
    De Leo V; Morgante G; Musacchio MC; Faldini E; Delia A; Petraglia F
    Expert Opin Drug Saf; 2006 Sep; 5(5):695-701. PubMed ID: 16907659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Iatrogenic menopause: a case report (author's transl)].
    Humbert B
    Sem Hop; 1981 Jun 8-15; 57(21-24):1115-6. PubMed ID: 6267710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
    Verbeke K; Dhont M; Vandekerckhove D
    Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
    Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
    Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonidine in the treatment of menopausal symptoms.
    Salmi T; Punnonen R
    Int J Gynaecol Obstet; 1979; 16(5):422-6. PubMed ID: 35414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV; Constantine G; Hwang E; Cheng RF;
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal hot flushes: a double blind comparison of placebo, ethinyl oestradiol and norgestrel.
    Dennerstein L; Burrows GD; Hyman G; Wood C
    Br J Obstet Gynaecol; 1978 Nov; 85(11):852-6. PubMed ID: 363136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The menopause. Vasomotor flushing: physiopathology and treatment].
    Uzan S; Salat-Baroux J
    Rev Fr Gynecol Obstet; 1986 Sep; 81(8):407-12. PubMed ID: 2876487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of veralipride for the treatment of vasomotor symptoms of menopause.
    Valencia MH; Arias Mde J; González CC; Marín IH; González JH; Campos ER; Rodríguez MA; Álvarez IM; Vargas MA; Flores JB; Haro SS; Bonilla MC; Escudero RB; Campero RA
    Menopause; 2014 May; 21(5):484-92. PubMed ID: 24065139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-hormonal treatment of hot flashes and other menopausal disorders].
    Ruf H; Lanza M
    Therapeutique; 1973 Dec; 49(10):703-5. PubMed ID: 4600155
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of different dopamine agonists and antagonists on post-menopausal hot flushes.
    Zichella L; Falaschi P; Fioretti P; Melis GB; Cagnacci A; Gambacciani M; Mancini S
    Maturitas; 1986 Oct; 8(3):229-37. PubMed ID: 3784919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Climacteric syndrome: comparison of several secondary therapies].
    Bianco V; Colombo A; Tassan Simonat P
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K; Rein E; Hedman C
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Agreal: clinical experience. Review of the literature].
    Brient-Clabaux J
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):143-6. PubMed ID: 3992111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.